KR20000057283A - 세팔로스포린 유도체 - Google Patents

세팔로스포린 유도체 Download PDF

Info

Publication number
KR20000057283A
KR20000057283A KR1019990704689A KR19997004689A KR20000057283A KR 20000057283 A KR20000057283 A KR 20000057283A KR 1019990704689 A KR1019990704689 A KR 1019990704689A KR 19997004689 A KR19997004689 A KR 19997004689A KR 20000057283 A KR20000057283 A KR 20000057283A
Authority
KR
South Korea
Prior art keywords
group
formula
alkyl
hydrogen
substituted
Prior art date
Application number
KR1019990704689A
Other languages
English (en)
Korean (ko)
Inventor
스프링거데인엠.
류빙와이.
디'안드레아스텐리브이.
후디마토마스더블유.
김옥케이.
Original Assignee
모스 데이빗 엠.
브리스톨-마이어즈 스퀴브 컴페니
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 모스 데이빗 엠., 브리스톨-마이어즈 스퀴브 컴페니 filed Critical 모스 데이빗 엠.
Publication of KR20000057283A publication Critical patent/KR20000057283A/ko

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/36—Methylene radicals, substituted by sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
KR1019990704689A 1996-11-27 1997-11-21 세팔로스포린 유도체 KR20000057283A (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US3404696P 1996-11-27 1996-11-27
US60/034,046 1996-11-27

Publications (1)

Publication Number Publication Date
KR20000057283A true KR20000057283A (ko) 2000-09-15

Family

ID=21873971

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019990704689A KR20000057283A (ko) 1996-11-27 1997-11-21 세팔로스포린 유도체

Country Status (17)

Country Link
EP (1) EP0966472A1 (zh)
JP (1) JP2001506607A (zh)
KR (1) KR20000057283A (zh)
CN (1) CN1238775A (zh)
AR (1) AR010650A1 (zh)
AU (1) AU734948B2 (zh)
BR (1) BR9713350A (zh)
CA (1) CA2272717A1 (zh)
CZ (1) CZ185399A3 (zh)
HU (1) HUP9903621A3 (zh)
IL (1) IL129437A0 (zh)
NO (1) NO992526L (zh)
NZ (1) NZ335892A (zh)
PL (1) PL334558A1 (zh)
TW (1) TW414796B (zh)
WO (1) WO1998023621A1 (zh)
ZA (1) ZA9710662B (zh)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20020085181A (ko) * 2001-05-07 2002-11-16 주식회사 엘지생명과학 신규 세팔로스포린계 항생제 및 이의 제조 방법
KR20020085178A (ko) * 2001-05-07 2002-11-16 주식회사 엘지생명과학 신규 세팔로스포린계 항생제 및 이의 제조 방법
KR20020085180A (ko) * 2001-05-07 2002-11-16 주식회사 엘지생명과학 신규 세팔로스포린계 항생제 및 이의 제조 방법
KR20020085176A (ko) * 2001-05-07 2002-11-16 주식회사 엘지생명과학 신규 세팔로스포린계 항생제 및 이의 제조 방법
KR20030071311A (ko) * 2002-02-28 2003-09-03 주식회사 엘지생명과학 신규 세팔로스포린 화합물 및 그의 제조방법

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6265394B1 (en) * 1997-07-31 2001-07-24 Bristol-Myers Squibb Company Bis quaternary MRSA cephem derivatives
KR20140034798A (ko) * 2011-05-18 2014-03-20 신젠타 파티서페이션즈 아게 아릴티오아세트아미드 유도체에 기반한 살곤충 화합물
CN105131018B (zh) * 2015-09-23 2017-12-26 浙江华方药业股份有限公司 一种头孢替唑酸的制备方法
CN114957056A (zh) * 2021-02-20 2022-08-30 帕潘纳(北京)科技有限公司 制备3-甲基-2-氯-4-甲基磺酰基苯甲酸甲酯及其中间体的方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3345366A (en) * 1967-02-15 1967-10-03 American Cyanamid Co Substituted 7-acetylamino cephalosporanic acids
US4148997A (en) * 1977-11-07 1979-04-10 Yeda Research And Development Co., Ltd. 7-[Sulfomethyl)phenyl]acetamidocephalosporin derivatives
US5567698A (en) * 1995-02-15 1996-10-22 Bristol-Myers Squibb Company Pyridinium thiomethyl substituted chepholosporin derivatives
US5620969A (en) * 1995-04-25 1997-04-15 Bristol-Myers Squibb Company Cephalosporin derviatives
US5734047A (en) * 1995-12-20 1998-03-31 Bristol-Myers Squibb Company Cephalosporin derivatives

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20020085181A (ko) * 2001-05-07 2002-11-16 주식회사 엘지생명과학 신규 세팔로스포린계 항생제 및 이의 제조 방법
KR20020085178A (ko) * 2001-05-07 2002-11-16 주식회사 엘지생명과학 신규 세팔로스포린계 항생제 및 이의 제조 방법
KR20020085180A (ko) * 2001-05-07 2002-11-16 주식회사 엘지생명과학 신규 세팔로스포린계 항생제 및 이의 제조 방법
KR20020085176A (ko) * 2001-05-07 2002-11-16 주식회사 엘지생명과학 신규 세팔로스포린계 항생제 및 이의 제조 방법
KR20030071311A (ko) * 2002-02-28 2003-09-03 주식회사 엘지생명과학 신규 세팔로스포린 화합물 및 그의 제조방법

Also Published As

Publication number Publication date
CA2272717A1 (en) 1998-06-04
NO992526D0 (no) 1999-05-26
ZA9710662B (en) 1999-05-26
WO1998023621A1 (en) 1998-06-04
TW414796B (en) 2000-12-11
IL129437A0 (en) 2000-02-17
AU734948B2 (en) 2001-06-28
HUP9903621A3 (en) 2001-05-28
JP2001506607A (ja) 2001-05-22
AU5365298A (en) 1998-06-22
EP0966472A1 (en) 1999-12-29
EP0966472A4 (zh) 1999-12-29
NZ335892A (en) 2001-07-27
NO992526L (no) 1999-05-26
HUP9903621A2 (hu) 2000-04-28
CN1238775A (zh) 1999-12-15
PL334558A1 (en) 2000-03-13
BR9713350A (pt) 2000-01-25
CZ185399A3 (cs) 1999-08-11
AR010650A1 (es) 2000-06-28

Similar Documents

Publication Publication Date Title
US5859256A (en) Cephalosporin antibiotics
US6265394B1 (en) Bis quaternary MRSA cephem derivatives
KR20000057283A (ko) 세팔로스포린 유도체
US5668284A (en) Cephalosporin derivatives
US5668290A (en) Substituted 4-thio pyridones
US5559108A (en) Cephalosporin derivatives
US6025352A (en) Cephalosporin antibiotics
US6093712A (en) Cephalosporin derivatives
US5734047A (en) Cephalosporin derivatives
US4371532A (en) Malonamidooxadethiacephem compounds
KR910006807B1 (ko) 카바펜엠 항생제의 제조방법
US6030965A (en) Cephalosporin antibiotics
US20020049191A1 (en) Cephalosporin derivatives
WO1997037997A1 (en) Cephalosporin derivatives
RU2172317C2 (ru) Производные цефалоспорина, содержащая их антибактериальная композиция, производные 2-аминотиазолов в качестве промежуточных соединений и способ их получения
MXPA99004823A (en) Cephalosporin derivatives
WO1999006048A1 (en) Bis quaternary mrsa cephem derivatives
EP1059293A1 (en) Novel amino chlorothiazole compounds
CZ163291A3 (cs) Nové beta«laktamové sloučeniny

Legal Events

Date Code Title Description
WITN Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid